Katsuyoshi Hashine

Summary

Affiliation: National Shikoku Cancer Center
Country: Japan

Publications

  1. ncbi Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, 13 Horinouchi, Matsuyama, 790 0007, Japan
    Int J Clin Oncol 10:45-50. 2005
  2. ncbi Correlation between cancer location and oncological outcome after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, Section of Cancer Prevention and Epidemiology, Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 19:855-60. 2012
  3. ncbi Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Int J Urol 18:813-9. 2011
  4. ncbi Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 41:571-6. 2011
  5. ncbi Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:502-8. 2009
  6. ncbi Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:381-6. 2009
  7. ncbi A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer
    Katsuyoshi Hashine
    National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 38:480-5. 2008
  8. ncbi Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 15:403-6. 2008
  9. ncbi Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama City, Ehime 790 0007, Japan
    Jpn J Clin Oncol 35:655-9. 2005
  10. ncbi Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience
    Noriyoshi Miura
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Jpn J Clin Oncol 40:1092-8. 2010

Collaborators

Detail Information

Publications23

  1. ncbi Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, 13 Horinouchi, Matsuyama, 790 0007, Japan
    Int J Clin Oncol 10:45-50. 2005
    ..Health-related quality of life (HR-QOL) is important when considering the treatment options for prostate cancer...
  2. ncbi Correlation between cancer location and oncological outcome after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, Section of Cancer Prevention and Epidemiology, Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 19:855-60. 2012
    ..To examine the association between cancer location, resection margins and oncological outcome in patients undergoing radical prostatectomy...
  3. ncbi Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Int J Urol 18:813-9. 2011
    ..To examine quality of life (QOL) for 3 years after radical retropubic prostatectomy (RRP) or permanent prostate brachytherapy (PPB) and to determine differences between the two procedures...
  4. ncbi Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 41:571-6. 2011
    ..This study examined the rate of Gleason pattern 5 and the influence of tertiary Gleason pattern 5 on oncological outcomes...
  5. ncbi Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:502-8. 2009
    ....
  6. ncbi Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:381-6. 2009
    ..A previous paper reported favorable results of intra-arterial chemotherapy in combination with radiotherapy for muscle-invasive bladder cancer. The current study will update those results...
  7. ncbi A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer
    Katsuyoshi Hashine
    National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 38:480-5. 2008
    ..The health-related quality of life (HRQOL) after a radical retropubic prostatectomy (RRP) or a permanent prostate brachytherapy (PPB) was prospectively compared at a single institute...
  8. ncbi Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 15:403-6. 2008
    ..To assess health-related quality of life (QOL) of bladder cancer patients following bladder preservation therapy (BPT)...
  9. ncbi Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama City, Ehime 790 0007, Japan
    Jpn J Clin Oncol 35:655-9. 2005
    ..The present study reports the long-term results of RT combined with hormone therapy for localized and locally advanced prostate cancer...
  10. ncbi Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience
    Noriyoshi Miura
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Jpn J Clin Oncol 40:1092-8. 2010
    ..To evaluate the efficacy and toxicity of docetaxel plus prednisolone treatment in Japanese patients with hormone-refractory prostate cancer (HRPC)...
  11. ncbi Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung
    Noriyoshi Miura
    Department of Urology, Shikoku Cancer Center, Ehime, Japan
    Jpn J Clin Oncol 38:623-5. 2008
    ..The abnormal shadow probably represented radiation pneumonitis. To the best of our knowledge, this is the first report of radiation pneumonitis caused by a migrated brachytherapy seed in the lung...
  12. ncbi [Primary urothelial carcinoma of the prostate: a case of spread along ducts and into seminal vesicles]
    Noriyoshi Miura
    Department of Urology, National Organization Shikoku Cancer Center
    Nihon Hinyokika Gakkai Zasshi 99:593-6. 2008
    ..pTis pd pN0 M0 Urothelial carcinoma G3 pL0 pV0) He had no adjuvant therapy, he is alive without any evidence of tumor recurrence after surgery...
  13. ncbi [Correlation of change in prostate-specific antigen and testosterone following withdrawal of androgen ablation after combination of radiation and hormone therapy]
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama, Japan
    Nippon Hinyokika Gakkai Zasshi 96:678-84. 2005
    ..Rise-width of PSA may be important for one of the predictors of failure with measurement of testosterone...
  14. ncbi [Health-related quality of life after radical prostatectomy or radiotherapy]
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama, Japan
    Nippon Hinyokika Gakkai Zasshi 96:495-502. 2005
    ..However, because of difference in background of each group, longitudinal investigation will need to aid patients in the decision making process...
  15. ncbi Predictor of response to salvage radiotherapy in patients with PSA recurrence after radical prostatectomy: the usefulness of PSA doubling time
    Kousaku Numata
    Department of Urology, Shikoku Cancer Center, 13 Horinouchi, Matuyama, Japan
    Jpn J Clin Oncol 35:256-9. 2005
    ..We assessed predictors of response to salvage radiotherapy (sRT) in patients with prostate-specific antigen (PSA) recurrence after radical prostatectomy...
  16. ncbi [Results of modified M-VAC chemotherapy for advanced urothelial carcinoma]
    Noriyoshi Miura
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama, Japan
    Nihon Hinyokika Gakkai Zasshi 98:589-94. 2007
    ..We retrospectively evaluated the efficacy and toxicity of modified M-VAC therapy for locally advanced or metastatic urothelial carcinoma...
  17. ncbi Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study
    Yoshiteru Sumiyoshi
    Department of Urology, Shikoku Cancer Center, Ko 16, Minamiumemoto, Mastuyama, Ehime 791 0280, Japan
    Jpn J Clin Oncol 40:967-72. 2010
    ..To assess the efficacy and safety of dietary supplements in patients with early stage prostate cancers who are managed expectantly...
  18. ncbi The efficacy of neoadjuvant androgen deprivation therapy as a prostate volume reduction before brachytherapy for clinically localized prostate cancer
    Shin Ebara
    Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700 8558, Japan
    Acta Med Okayama 61:335-40. 2007
    ..A three-month course of the neoadjuvant LH-RH agonist indicated a sufficient volume reduction effectiveness for a large prostate volume...
  19. ncbi [Utility of prostate specific antigen doubling time in repeat biopsy for prostate cancer]
    Koji Azuma
    Department of Urology, Shikoku Cancer Center
    Nippon Hinyokika Gakkai Zasshi 97:42-7. 2006
    ..CONCLUSION: When we considered prostate repeat biopsy, it was thought that PSA-DT could be one important material, but it was limitation for indication as to other PSA-related parameters...
  20. ncbi [A case of hormone-refractory prostate cancer (HRPC) with tumor fever responding to docetaxel plus prednisolone therapy]
    Noriyoshi Miura
    Dept. of Urology, Shikoku Cancer Center
    Gan To Kagaku Ryoho 33:841-4. 2006
    ..The patient has survived for twelve months after starting docetaxel plus prednisolone therapy, without serious adverse events...
  21. ncbi [Two cases of second bladder cancer after radiotherapy for prostate cancer]
    Kousaku Numata
    Department of Urology, Shikoku Cancer Center
    Nippon Hinyokika Gakkai Zasshi 96:466-9. 2005
    ..We report two cases of second bladder cancer after radiotherapy for prostate cancer. It is important to take second cancer into consideration for long-term after the patients are treated with radiotherapy...
  22. ncbi Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer
    Kousaku Numata
    The Department of Urology, Shikoku Cancer Center
    Hinyokika Kiyo 53:99-104. 2007
    ..E-E therapy was considered to be an active oral regimen and well-tolerated for outpatients with hormone-refractory prostate cancer in Japanese patients...
  23. ncbi The preliminary results of docetaxel-prednisolone combination therapy for the Japanese patients with hormone-refractory prostate cancer
    Kousaku Numata
    The Department of Urology, Shikoku Cancer Center
    Hinyokika Kiyo 53:93-7. 2007
    ..Three patients with nodal metastases and 1 patient with liver metastasis had partial response. Combined docetaxel and prednisolone was shown to be effective and feasible in Japanese patients...